Clinical Trial Update: Safety and Protective Efficacy of Pb(PfCS@UIS4) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and protective efficacy of Pb(PfCS@UIS4); results completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Controlled Human Malaria Infection
• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Pb(PfCS@UIS4)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Malaria,Falciparum, Plasmodium Falciparum | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-15